Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Clinical trial NCT06890923 · RECRUITING
Trial details
- NCT number
- NCT06890923
- Sponsor
- Tiziana Life Sciences LTD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-04
- Primary completion
- 2026-04-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.